Consumer Cyclical -
Apparel - Manufacturers - NYSE - US
$ 3.88
-3.79 %
$ 631 M
Market Cap
190.5
P/E
1. INTRINSIC VALUE
Balance Sheet
FIGS, Inc.
| Current Assets | 383 M |
| Cash & Short-Term Investments | 245 M |
| Receivables | 8.62 M |
| Other Current Assets | 129 M |
| Non-Current Assets | 127 M |
| Long-Term Investments | 27.5 M |
| PP&E | 85.8 M |
| Other Non-Current Assets | 13.7 M |
| Current Liabilities | 90.1 M |
| Accounts Payable | 9.4 M |
| Short-Term Debt | 21.2 M |
| Other Current Liabilities | 59.5 M |
| Non-Current Liabilities | 42.5 M |
| Long-Term Debt | 42.4 M |
| Other Non-Current Liabilities | 83 K |
EFFICIENCY
Earnings Waterfall
FIGS, Inc.
| Revenue | 556 M |
| Cost Of Revenue | 180 M |
| Gross Profit | 376 M |
| Operating Expenses | 285 M |
| Operating Income | 2.26 M |
| Other Expenses | -455 K |
| Net Income | 2.72 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
FIGS, Inc.
| Net Income | 2.72 M |
| Depreciation & Amortization | 6.69 M |
| Capital Expenditures | -17 M |
| Stock-Based Compensation | 42.7 M |
| Change in Working Capital | 19.7 M |
| Others | 25.7 M |
| Free Cash Flow | 64.1 M |
Wall Street Analysts Price Targets
FIGS, Inc.
Wall Street analysts predict an average 1-year price target for FIGS of $8.83 , with forecasts ranging from
a
low of
$7 to a high of $15 .
FIGS Lowest Price Target
Wall Street Target
7 USD
80.41%
FIGS Average Price Target
Wall Street Target
8.83 USD
127.66%
FIGS Highest Price Target
Wall Street Target
15 USD
286.60%
4. DIVIDEND
ANALYSIS
FIGS does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
FIGS, Inc.
Sold
0-3 MONTHS
9.33 K USD 1
3-6 MONTHS
420 K USD 1
6-9 MONTHS
250 K USD 2
9-12 MONTHS
161 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 fin.
businesswire.com
- 2 weeks ago
Stock Picks From Seeking Alpha's March 2025 New Analysts
In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and investment strategies. Our analysts covered a diverse set of industries—including IT, financials, utilities, materials, and mining—and provided ratings ranging from Strong Sell to Strong Buy. Top picks include C3.ai, Robinhood, Central Puerto, CF Industries, and Kyndryl.
seekingalpha.com
- 4 weeks ago
FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the “Board”), effective April 1, 2025 (the “Effective Date”). Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Co.
businesswire.com
- 4 weeks ago
Figs, Inc. - Slow Growth Is Still Growth
Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO.
seekingalpha.com
- 1 month ago
FIGS Shows Significant U.S. Weakness But Continues To Trade At 50x NOPAT
FIGS, Inc.'s earnings show mixed results, with strong international growth but declining U.S. sales and weak FY25 guidance, raising concerns about profitability and customer acquisition. Despite strong product innovation, FIGS struggles with high marketing costs, poor customer acquisition, and stagnating U.S. sales, making its high valuation unjustifiable. International expansion is promising but comes with lower margins; new management might improve execution, but significant challenges remain.
seekingalpha.com
- 1 month ago
Figs (FIGS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
- 2 months ago
FIGS, Inc. (FIGS) Q4 2024 Earnings Call Transcript
FIGS, Inc. (NYSE:FIGS ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer John Kernan - TD Cowen Dana Telsey - Telsey Group Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Ashley Owens - KeyBanc Capital Markets Nathan Feather - Morgan Stanley Operator Good afternoon, everyone, and thank you for joining today's FIGS Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Reagan, and I'll be your moderator today.
seekingalpha.com
- 2 months ago
Figs (FIGS) Q4 Earnings Meet Estimates
Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.
zacks.com
- 2 months ago
FIGS Releases Fourth Quarter and Full Year 2024 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2024 Financial Highlights Net revenues were $151.8 million, an increase of 4.8% year over yea.
businesswire.com
- 2 months ago
Countdown to Figs (FIGS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Figs (FIGS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
zacks.com
- 2 months ago
FIGS Announces Participation in the Raymond James 46th Annual Institutional Investors Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Raymond James 46th Annual Institutional Investors Conference on Monday, March 3, 2025, at 11:00 a.m. ET. The audio portion of the fireside chat will be web.
businesswire.com
- 2 months ago
FIGS Announces Date of Fourth Quarter and Full Year 2024 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a f.
businesswire.com
- 2 months ago
8. Profile
Summary
FIGS, Inc. FIGS
COUNTRY
US
INDUSTRY
Apparel - Manufacturers
MARKET CAP
$ 631 M
Dividend Yield
0.00%
Description
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.
Contact
2834 Colorado Avenue, Santa Monica, CA, 90404
https://www.wearfigs.com
IPO
Date
May 27, 2021
Employees
303
Officers
Mr. Todd A. Maron
Chief Legal Officer & Secretary
Ms. Jami Pinto
Chief Global Product & Sustainability Officer
Ms. Sarah Oughtred
Chief Financial Officer
Mr. Mark Bixby
Chief Technology Officer
Ms. Devon Duff Gago
Chief Business Development Officer
Mr. Thomas D. Shaw C.F.A.
Senior Vice President of Investor Relations
Ms. Catherine Eva Spear
Co-Founder, Chief Executive Officer & Director
Ms. Heather L. Hasson
Co-Founder & Executive Chairman